CATCo Regulatory News (CAT)

25 Nov 2005 15:33

Cambridge Antibody Tech Group PLC25 November 2005 NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIALRESPONSIBILITY OR CONNECTED PERSONS This form is intended for use by an issuer to make a RIS notification requiredby DR 3.1.4R(1). (1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.(2) An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8,13, 14, 16, 23 and 24.(3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.(4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. Please complete all relevant boxes should in block capital letters. 1. Name of the issuer CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC 2. State whether the notification relates to (i) a transaction notified inaccordance with DR 3.1.4R(1)(a); or (ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (asextended by section 328) of the Companies Act 1985; or (iii) both (i) and (ii) (ii) 3. Name of person discharging managerial responsibilities/director DIANE MELLETT 4. State whether notification relates to a person connected with a persondischarging managerial responsibilities/director named in 3 and identify theconnected person AS IN 3 ABOVE 5. Indicate whether the notification is in respect of a holding of the personreferred to in 3 or 4 above or in respect of a non-beneficial interest AS IN 3 ABOVE 6. Description of shares (including class), debentures or derivatives orfinancial instruments relating to shares ORDINARY 10 PENCE SHARES 7. Name of registered shareholders(s) and, if more than one, the number ofshares held by each of them GREENWOOD NOMINEES LIMITED 8 State the nature of the transaction PURCHASE OF SHARES FOLLOWING EXERCISE OF OPTION 9. Number of shares, debentures or financial instruments relating to sharesacquired 7597 10. Percentage of issued class acquired (treasury shares of that class shouldnot be taken into account when calculating percentage) 0.014% 11. Number of shares, debentures or financial instruments relating to sharesdisposed NIL 12. Percentage of issued class disposed (treasury shares of that class shouldnot be taken into account when calculating percentage) NIL 13. Price per share or value of transaction £2.42 14. Date and place of transaction 25 NOVEMBER 2005 LONDON 15. Total holding following notification and total percentage holding followingnotification (any treasury shares should not be taken into account whencalculating percentage) 22,659 0.043% 16. Date issuer informed of transaction 25 NOVEMBER 2005 If a person discharging managerial responsibilities has been granted options bythe issuer complete the following boxes 17 Date of grant .................................... 18. Period during which or date on which it can be exercised .................................... 19. Total amount paid (if any) for grant of the option .................................... 20. Description of shares or debentures involved (class and number) .................................... .................................... 21. Exercise price (if fixed at time of grant) or indication that price is to befixed at the time of exercise .................................... 22. Total number of shares or debentures over which options held followingnotification .................................... 23. Any additional information THE OPTION WHICH WAS EXERCISED WAS DUE TO IRREVOCABLY LAPSE ON 27 NOVEMBER 2005IF IT HAD NOT BEEN EXERCISED PRIOR TO THAT DATE. 24. Name of contact and telephone number for queries JUSTIN HOSKINS 01223 898 589 Name and signature of duly authorised officer of issuer responsible for makingnotification JUSTIN HOSKINS, COMPANY SECRETARY Date of notification 25 NOVEMBER 2005 END This information is provided by RNS The company news service from the London Stock Exchange